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ABSTRACT Human apolipoprotein E (apoE) is a 299-amino-acid protein with a molecular weight of 34 kDa. The difference
between the apoE3 and apoE4 isoforms is a single residue substitution involving a Cys-Arg replacement at residue 112. ApoE4 is
positively associated with atherosclerosis and late-onset and sporadic Alzheimer’s disease (AD). ApoE4 and its C-terminal
truncated fragments have been found in the senile plaques and neuroﬁbrillary tangles in the brain of AD patients. However, detail
structural information regarding isoform and domain interaction remains poorly understood. We prepared full-length, N-, and
C-terminal truncated apoE3 and apoE4 proteins and studied their structural variation. Sedimentation velocity and continuous size
distribution analysis using analytical ultracentrifugation revealed apoE372-299 as consisting of amajor specieswith a sedimentation
coefﬁcient of 5.9. ApoE472-299 showed a wider andmore complicated species distribution. Both apoE3 and E4 N-terminal domain
(1–191) existed with monomers as the major component together with some tetramer. The oligomerization and aggregation of
apoE protein increased when the C-terminal domain (192–271) was incorporated. The structural inﬂuence of the C-terminal
domain on apoE is to assist self-association with no signiﬁcant isoform preference. Circular dichroism and ﬂuorescence studies
demonstrated that apoE472-299 possessed a more a-helical structure with more hydrophobic residue exposure. The structural
variation of the N-terminal truncated apoE3 and apoE4 protein provides useful information that helps to explain the greater
aggregation of the apoE4 isoform and thus has implication for the involvement of apoE4 in AD.
INTRODUCTION
Human apolipoprotein E (apoE) is a 34-kDa protein
containing 299 amino acid residues that mediates the
binding of very low-density lipoprotein (VLDL) and
intermediate-density lipoprotein (IDL) to the low-density
lipoprotein (LDL) receptor and to LDL receptor-related
protein (Siest et al., 1995; Selkoe, 2001; Van Bockxmeer
et al., 1994; Demant et al., 1991; Kao et al., 1995; Dong et al.,
1994; Lalazar and Mahley, 1989). There are three major
isoforms of human apoE (namely apoE2, apoE3, and
apoE4), which are the products of three alleles (e2, e3, and
e4) at a single gene locus on chromosome 19q13.2. The most
common isoform of apoE is apoE3, which contains cysteine
and arginine at positions 112 and 158. Both positions contain
cysteine residues in apoE2 and arginine residues in apoE4
(Fig. 1). Strong correlation of e4 allele with dyslipidemia and
coronary heart disease (CHD) has been demonstrated. The
estimated CHD odds associated with the e4 allele is greater
than that for any other known genetic abnormality. The
association of e4 allele with CHD remains signiﬁcantly high
in women, and both sexes combined, after adjustment for
traditional coronary risk factors and plasma lipids. ApoE4
homozygosity is also a determinant of restenosis after
coronary angioplasty (Van Bockxmeer et al., 1994). ApoE-
deﬁcient (apoE()) mice develop atherosclerosis spontane-
ously and the severity is enhanced by a high-cholesterol diet.
The apoE4 isoform also contributes to the pathogenesis of
Alzheimer’s disease (AD; Selkoe, 2001; Schellenberg, 1995;
Marx, 1993; Pericak-Vance and Haines, 1995; Strittmatter
and Roses, 1995; Polvikoski et al., 1995; Henderson et al.,
1995; Huang et al., 2001; Nathan et al., 1994; Sanan et al.,
1994; Raffai and Weisgraber, 2003; Chauhan, 2003). The e4
allele is associated with both familial late-onset and sporadic
AD, and the gene dose of e4 is a major risk factor for the
disease. Accumulated apoE is found in the senile plaques and
neuroﬁbrillary tangles (NFT) seen on postmortem examina-
tion of the brains of AD patients. AD patients who are
homozygous for the e4 allele exhibit more highly developed
senile plaques at autopsy. In cultures of dorsal root ganglion
neurons, apoE3 increases neurite outgrowth, whereas apoE4
decreases outgrowth (Nathan et al., 1994). ApoE associates
with b-amyloid peptides (Ab) to form novel monoﬁbrils
(Sanan et al., 1994). Furthermore, the neuropathology and
the apoE proﬁle of aged chimpanzees have implications for
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AD (Gearing et al., 1994) and C-terminal truncated apoE4
causes AD-like neurodegeneration and behavioral deﬁcits in
transgenic mice (Harris et al., 2003).
Recent evidence has indicated that apoE is folded into two
independent structural domains (Dong et al., 1994). Limited
thrombolytic digestion provides two large fragments with one
fragment corresponding to residues 1–199, a 22-kDa
N-terminal domain and the other one to residues 216–299,
a 10-kDa C-terminal domain (Fig. 1). Crystallographic
studies suggest an amphipathic, extended, and antiparallel
four-helix bundle for the N-terminal domain (Wilson et al.,
1991). The region of residues 136–158, which is rich in basic
amino acids, is involved in LDL receptor binding (Siest et al.,
1995). The apoE4 isoform binds preferentially to VLDL and
the interaction of Arg-61 with Glu-255 may stabilize an
extended helical structure in the carboxyl terminus to
accommodate a larger, less-curved VLDL surface (Dong
and Weisgraber, 1996). The C-terminal domain of apoE
beyond residue 191 contains three predicted helices, namely
residues 203–223, 225–266, and 268–289 (Wilson et al.,
1991; De Pauw et al., 1997). The end of the second helix may
play a key role in lipid binding in apoE and lipoprotein
interaction (Westerlund and Weisgraber, 1993; Weisgraber,
1994). The third helix (G* helix) induces the aggregation of
C-terminus that becomes monomer after the polar/charged
mutation of ﬁve residues (Phe-257, Trp-264, Val-269, Leu-
279, and Val-287; Fan et al., 2004). Choy et al. (2004) have
also shown intermolecular coiled-coil helical formation in the
C-terminal domain. The C-terminal region of apoE may
also interact with Ab in forming NFT (Huang et al., 2001).
TheN-terminal andC-terminal truncated apoE4 proteins have
been found to occur in AD brains and induced intracellular
NFT-like inclusions in cultured neurons (Huang et al., 2001).
However, the structural characters of apoE isoforms that may
lead to the differences in molecular pathogenesis of AD
remain poorly understood.
To elucidate the structural difference between apoE3 and
apoE4, especially with respect to N-terminal and C-terminal
truncation, we have expressed full-length and N- or
C-terminal-truncated human apoE3 and apoE4 proteins and
compared secondary structure, tertiary structure, and quater-
nary species distribution.
MATERIALS AND METHODS
Plasmids
The pET-29a (1) (Novagen, Madison, WI) vectors used carry a C-terminal
HisTag sequence and multiple cloning sites beyond the f1 origin. This
kanamycin-resistant vector was transformed into the BL21 (DE3) strain of
Escherichia coli. The expression of protein was induced with 1.0 mM
isopropyl-1-thio-b-D-galactoside (IPTG) and the cells were harvested at
18C for overnight or 37C for 3–5 h.
Construction of human apoE3 expression vectors
The human apoE3 cDNA fragments were ﬁrst ampliﬁed by PCR and ligated
into pGEM-T vector (Promega, Madison, WI). The forward primer was 5#-
CATATGAAGGTGGAGCAAGCGGTG, and the reverse primer was 5#-
GCTCGAGTGATTGTCGCTGGGCACA. The apoE3 cDNA-carried T
vectors were then digested with NdeI and XhoI. Finally, the 0.9-kb fragment
end product was ligated to the 5.2-kb NdeI-XhoI fragment from pET-29a
(1). This in turn resulted in a 6.1-kb pET-apoE3 vector, in which apoE3
cDNA was driven by the T7 promoter and the protein was C-terminally
fused to a HisTag sequence (Ser2-His6).
Construction of N-terminal or C-terminal truncated
apoE3 expression vectors
The pET-apoE3 vector was used as the template. The apoE341-299,
apoE372-299, apoE31-191, apoE31-231, and apoE31-271 cDNA fragments were
ampliﬁed by PCR and ligated into pGEM-T vector (Promega). For
apoE341-299, the forward primerwas 5#-CATATGCAGACACTGTCTGAG-
CAGG and for apoE372-299, 5#-CATATGAAGGCCTACAAATCG-
GAACT. The reverse primer for apoE341-299 and apoE372-299 was
FIGURE 1 Human apolipoprotein E. The
model structure illustrates the structural regions
where deletions were made (deletion of helix 1,
residues 1–40; helices 1 and 2, residues 1–71;
C-terminal domain, 192–299; helices 6 and 7,
232–299; and helix 7, 272–299) and also shows
the polymorphic site (residue 112) that distin-
guished apoE3 from apoE4. The structure was
modiﬁed from apoE299_20K (S. Y. Sheu,
unpublished data).
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5#-CTCGAGGTGATTGTCGCTGGGCACA. The forward primer for
apoE31-191, apoE31-231, and apoE31-271 was 5#-TATACATATGAAGGTG-
GAGCAAG. The reverse primer for apoE31-191 was 5#-AACTCGAGCCG-
CACGCGGC; for apoE31-231, 5#-AACTCGAGCTCGTCCAGGCGG; and
for apoE31-271, 5#-AACTCGAGGTCTTCCACCAGGG. After digesting
withNdeI andXhoI, the cDNA fragment end products were ligated to the 5.2-
kb NdeI-XhoI fragment from pET-29a (1).
Construction of human apoE4 expression vectors
Site-directed mutagenesis (Braman et al., 1996) was used to construct
pET-apoE4, pET-apoE441-299, pET-apoE472-299, pET-apoE41-191, pET-
apoE41-231, and pET-apoE41-271 vectors. The forward primer was 5#-
GAGGACGTGCGCGGCCGCCTG and the reverse primer was 5#-AGG-
CGGCCGCGCACGTCCTCC. Brieﬂy, pET-apoE3, pET-apoE341-299, pET-
apoE372-299, pET-apoE31-191, pET-apoE31-231, and pET-apoE31-271 vectors
were used as templates and the desired primers were used to mutate the Cys-
112 codon to the Arg-112 codon by PCR using Pfu DNA polymerase
(Promega). After 16–18 temperature cycles, mutated plasmid containing
staggered nicks were generated. The PCR products were then treated with
DpnI (New England Biolabs, Beverly, MA) to digest the pET-apoE3
templates. Finally, the nicked vector DNA incorporating the desired mu-
tations was transformed into E. coli and their DNA sequence was checked by
autosequencing.
Puriﬁcation of the full-length, N-terminal, and
C-terminal truncated apoE proteins
After induced by IPTG at 18C overnight (apoE full-length, apoE1-191,
apoE1-231, and apoE1-271) or 37C for 3–5 h (apoE41-299 and apoE72-299), the
cells were centrifuged at 6000 3 g at 4C for 10 min. The supernatant was
removed and the cell pellets were again suspended in the binding buffer
(4 mM imidazole, 300 mM sodium chloride, and 20 mM Tris-HCl, pH 7.9).
The cells were sonicated by 60 10-s bursts at 300 W with a 10-s cooling
period between each burst. The lysate was centrifuged at 10,000 3 g for
25 min at 4C to pellet the cellular debris. One milliliter of the 50% Ni-NTA
slurry was equilibrated with the binding buffer and then added to the cleared
lysate and the solution mixed gently at 4C for 60 min. The lysate-Ni-NTA
mixture was loaded into a column and washed with the washing buffer
(40 mM imidazole, 300 mM sodium chloride, and 20 mMTris-HCl, pH 7.9).
Finally, apoE proteins were eluted with the elution buffer (400 mM
imidazole, 300 mM sodium chloride, and 20 mM Tris-HCl, pH 7.9). The
purity of all recombinant proteins was estimated to be .95% by the SDS-
PAGE. The molar masses of the puriﬁed apoE3 and apoE4 proteins (35,365
and 35,418 Da, respectively) were determined by electrospray mass
spectrometry and agreed with the theoretical values. The molecular weights
of apoE41-299, apoE72-299, apoE1-191, apoE1-231, and apoE1-271, were 30, 27,
23, 28, and 33 kDa, respectively, as anticipated (Fig. 2). Typical yields of the
full-length apoE3 and apoE4 proteins were 1.0 mg/l and those of apoE3 and
apoE4 N- or C-terminal truncated proteins were 5.0 mg/l after puriﬁcation.
Buffer change
The puriﬁed proteins were concentrated by Amicon Ultra-4 centrifugal ﬁlter
devices (Millipore, Billerica, MA) with molecular weight cutoff at 10 kDa.
The puriﬁed proteins were concentrated to 5–10 mg/ml and diluted to 0.5–
1.0 mg/ml by PBS (4 mM monosodium dihydrogen phosphate, 16 mM
disodium monohydrogen phosphate, and 150 mM sodium chloride, pH 7.3).
The result was that after repeating the concentration-dilution procedure ﬁve
times, the elution buffer had been fully replaced.
Sedimentation velocity
Sedimentation velocity experiments were performed using a Beckman
model XL-A analytical ultracentrifuge (Fullerton, CA). Before experiments,
samples in PBS buffer were diluted to 0.15, 0.50, or 1.00 mg/ml. Samples
(400 ml) and reference (440 ml) solutions were loaded into double-sector
centerpieces and mounted in a Beckman An-50 Ti rotor. Experiments were
performed at 20C with a rotor speed of 40,000 rpm. Absorbance of the
sample at 280 nm was monitored in a continuous mode, time interval of
480 s, and a step size of 0.002 cmwithout averaging. Multiple scans at differ-
ent time points were ﬁtted to a continuous size distribution (see below) by
using the program SEDFIT (Schuck, 2000; Schuck et al., 2002) (http://
www.analyticalultracentrifugation. com/download.htm) and to a monomer-
tetramer rapid self-association model (see below) by using the program
SEDPHAT (Schuck, 2003) (http://www.analyticalultracentrifugation.com/
sedphat/sedphat.htm). To evaluate the weight-average sedimentation coeff-
icients (sw), the following equation, which was modiﬁed from Fujita (1975)
and Baldwin (1953), was used (Eq. 1).
swðcpÞ ¼1=2v23 d=dt3 log½12=c0r2p
Z
ðc0 cðr; tÞÞrdr;
(1)
in which sw(cp) is the weight-average sedimentation coefﬁcient at the plateau
concentration cp and rp, the plateau radius value. The program SEDFIT
containing this equation was used for calculating sw (Schuck, 2003).
Continuous size distribution analysis
The continuous size (mass or sedimentation coefﬁcient) distribution of the
proteins can be determined by using ﬁnite element solutions of the Lamm
equation combined with size distribution analysis techniques by regulariza-
tion (Schuck, 2000; Schuck et al., 2002). In brief, the observed sedimenta-
tion proﬁles are described as a superimposition of the contributions of each
subpopulation c(s) of particles with sedimentation coefﬁcients between s and
s 1 ds by the integral equation (Eq. 2).
aðr; tÞ ﬃ
Z
cðsÞLðs;D;r; tÞds; (2)
where a(r,t) represents the experimentally observed signal at radius r and
time t. L(s,D,r,t) denotes the sedimentation proﬁle of an ideally sedimenting
monodisperse species of sedimentation coefﬁcient s and diffusion constant
D, calculated as the solution to the Lamm equation (Lamm, 1929). Similarly,
the size distribution can be calculated as a molar mass distribution, c(M),
according to Eq. 3.
FIGURE 2 SDS-PAGE analysis of the recombinant human apolipopro-
tein E. Proteins were analyzed on a gradient (4–12%) gel and stained with
Coomassie blue. Lane 1, molecular mass markers; lane 2, apoE3; lane 3,
apoE4; lane 4, apoE341-299; lane 5, apoE372-299; lane 6, apoE441-299; lane 7,
apoE472-299; lane 8, apoE31-191; lane 9, apoE31-231; lane 10, apoE31-271; lane
11, apoE41-191; lane 12, apoE41-231; lane 13, apoE41-271.
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aðr; tÞ ﬃ
Z
cðMÞLðM;D;r; tÞdM: (3)
The distributions were calculated using maximum entropy regularization,
selecting the most parsimonious distribution within a predeﬁned conﬁdence
level p for the quality of ﬁt. An average anhydrous ratio (f/f0) representing
the ratio of frictional coefﬁcient to that of an anhydrous sphere was
employed, together with the Stokes-Einstein and the Svedberg equation, for
estimating the diffusion coefﬁcientD for all species (Schuck, 2000). All size
distributions were solved on a conﬁdence level of p ¼ 0.95 or 0.68, a best
ﬁtted f/f0, and a resolution N of 250 sedimentation coefﬁcients between 0.1
and 25.0 S or molar mass between 1 and 1000 kDa, respectively.
Monomer-tetramer rapid self association
model analysis
For rapidly associating systems, ﬁnite element solutions of the Lamm
equation
@c=@t¼1=rð@=@rðswðcðrÞÞv2r2cDgðcðrÞÞr@c=@rÞÞ;
(4)
with local weight-average sedimentation coefﬁcients sw and gradient-
average diffusion coefﬁcients Dg were calculated as described previously
(Schuck, 2003, 1998; Cox, 1969). For Lamm equation solutions with
hydrodynamic repulsive nonideality, the local weight-average sedimentation
coefﬁcients were multiplied with a factor of 1/(1 1 ksctot(r)), as described
previously (Solovyova et al., 2001).
Dynamic light scattering
The dynamic light scattering (DLS) experiment was performed using
a Proterion Protein Solution (Piscataway, NJ) DynaPro-MS/X dynamic
light-scattering instrument. The laser power was set 20%, acquisition time
was 10 s, and the temperature was 20C. Intensity, contents, hydrodynamic
radius (R), and polydispersity of the protein sample in PBS (pH 7.3) were
real-time detected and analyzed by the software Dynamics V6. The total
detecting time of each sample was 30–40 min.
Circular dichroism spectrometry
Circular dichroism (CD) spectrometry was performed using a Jasco J-810
spectropolarimeter (Easton, MD). Spectra of the sample dissolved in PBS
(pH 7.3) were recorded at 30C using 0.01-cm quartz cuvettes with a
wavelength range of 190–250 nm at a step size of 0.2 nm. Signal averaging
time was 1.0 s, and the slit bandwidth was 2 nm. The mean residue ellipticity
([Q]) at each wavelength was calculated from Eq. 5,
½Q ¼MRW3 ul=103 l3 c; (5)
where MRW is the mean residue weight, ul is the measured ellipticity
in degree at wavelength l, l is the cuvette pathlength (0.01 cm), and c is
the protein concentration in g/ml. The deconvolution was performed
using online CD analysis by DICHROWEB (Lobley and Wallace, 2001;
Lobley et al., 2002) (http://www.cryst.bbk.ac.uk/cdweb/html/home.html).
DICHROWEB offers several important pieces of analysis software for
secondary structure determination, such as CONTINLL (Provencher and
Glockner, 1981; Van Stokkum et al., 1990), SELCON3 (Sreerama and
Woody, 1993; Sreerama et al., 1999), and K2D (Andrade et al., 1993).
ANS ﬂuorescence spectrometry
Fluorescent dye binding experiments with 1-anilino-8-naphthalenesulfonic
acid (ANS) as a probe were performed using Perkin-Elmer LS 50B
luminescence spectrometer (Foster City, CA). The ﬂuorescence emission of
ANS is known to increase upon binding to accessible hydrophobic region of
a protein (Semisotnov et al., 1991; Rogers et al., 1997). A ﬁxed
concentration of ANS (250 mM) was mixed with the protein (3 mM) in
PBS (pH 7.3). The excitation wavelength was set at 395 nm and the emission
spectrum was monitored from 400 to 600 nm wavelength. The area of the
spectrum was calculated by the peak-ﬁtting module of the Origin program
(OriginLab, Northampton, MA). The average emission wavelength, Ælæ, was
calculated using Eq. 6,
Ælæ¼SðF3 lÞ=SF; (6)
where F is the ﬂuorescence intensity and l is the wavelength (Sa´nchez del
Pino and Fersht, 1997).
RESULTS
Hydrodynamic behaviors and sw of apolipoprotein
E3 and E4 by sedimentation velocity
The sedimentation boundary of the sedimentation velocity
data of 0.50 mg/ml of apoE3 protein at 480-s intervals is
shown in Fig. 3. The open circles in Fig. 3 A represent the
experimental data and solid lines represent the best-ﬁt
sedimentation proﬁles to a continuous size distribution
analyzed by SEDFIT. The grayscale of residual bitmap and
random distribution of residuals (Fig. 3, B and C),
respectively, both show a high quality of ﬁt. In the ﬁtting
process, maximum entropy regularization (p ¼ 0.95 or 0.68)
and resolution of n ¼ 250 were used according to Schuck
(2000). The ﬁtting results are shown as calculated c(s) versus
sedimentation coefﬁcient (Fig. 3, D and E) or calculated
c(M) versus mass (Fig. 3 F). The distribution of each species
was more clearly deﬁned when a regularization of p ¼ 0.68
was used (Fig. 3 E). ApoE4 and the other truncated frag-
ments at different protein concentrations (0.15–1.00 mg/ml)
were also analyzed (Table 1). Depending on the sequence
and size of proteins, the partial speciﬁc volume of all the pro-
teins was calculated (;0.73 ml/g) by program SEDNTERP
(Laue et al., 1992) and so were molar extinction coefﬁcients.
Root mean square deviation (rmsd) of ﬁtting to the
continuous size distribution model was from 0.00384 to
0.00773 (Table 1). According to Schuck (2000) and Schuck
et al. (2002), the ﬁt in our studies was good and showed
a high quality (rmsd , 0.01). Every sedimentation velocity
experiment was repeated twice and similar results were
obtained.
The sw value was calculated by second moment in-
tegration (Schuck, 2003; Table 1). The sw values of apoE and
apoE1-271 proteins were from 6.1 to 6.6 S and did not show
any signiﬁcant difference. The C-terminal truncated apoE1-191
showed the lowest sw (2.6–3.0 S), whereas apoE31-231 had
an sw of 3.8–4.2 S and apoE41-231 had an sw of 3.1–3.6 S.
ApoE341-299 and apoE441-299 proteins showed lower sw
values (4.4 and 3.7 S) at 0.15 mg/ml and higher sw values
(4.8 and 4.3 S) at 0.50 or 1.00 mg/ml, respectively. Finally,
the sw of the apoE472-299 protein had signiﬁcantly increased
(from 6.4 to 7.2) at a higher protein concentration, but
apoE372-299 did not.
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Size distribution of full-length apoE3 and
apoE4 proteins
Size distribution of apoE3 and apoE4 full-length proteins
showed very similar patterns (Fig. 4, A and B). Fitting to the
continuous size distribution model showed overlapping
peaks. To estimate each contributing component, the per-
centage and sw of the distribution curve by different integral
range were analyzed with the integral function of SEDFIT
(Table 2). There were four major species below s ¼ 10. The
large components (s . 10), with their lower content and
broad distribution, were calculated as a single region. Both
apoE3 and apoE4 proteins were separated into a ﬁve region
distribution. The distribution of these components was very
similar for both protein concentrations (0.15 mg/ml and
0.50 mg/ml). Concentration-dependent variation was ob-
served. The aggregation species corresponding to s¼ 15.1 of
apoE3 showed 6% increase and the species at s ¼ 7.9
increased by 5%, whereas the smaller species at s ¼ 4.0 and
5.9 showed 11% decreases. A similar trend was also
observed in apoE4 species corresponding to s ¼ 7.8, 9.8,
and 14.9, which increased by 23% and those of s ¼ 3.9 and
5.8, which decreased by 23%. Furthermore, at higher protein
concentration, large species (s. 10) were more signiﬁcantly
increased for the apoE4 protein (by 15%), compared to
FIGURE 3 Sedimentation velocity experiments of apoE3. A ﬁxed initial
protein concentration at 0.50 mg/ml was used for the proteins. Analytical
ultracentrifugation was performed at a rotor speed of 40,000 rpm, rotor
temperature of 20C in PBS (pH 7.3), and A280nm was scanned. The radial
data collecting interval was 0.002 cm and time interval of scans was 480 s.
(A) Circles represent the observed spectrum and solid lines are computer-
generated results by ﬁtting the experimental data to the Lamm equation with
the SEDFIT program. (B) Grayscale of residual bitmap. (C) Residuals plot-
ted as a function of radial position. (D and E) Continuous sedimentation coef-
ﬁcients distribution of the apoE3 proteins at the regularization of p ¼ 0.95
and 0.68. (F) Continuous molar mass distribution of the apoE3 protein at
the regularization of p ¼ 0.95.
TABLE 1 Sedimentation analysis of full-length and N-terminal
truncated apoE3 and apoE4 proteins
Concentration (mg/ml) RMSD* sw
y (S)
ApoE3 0.15 0.00523 6.6
0.50 0.00746 6.5
ApoE4 0.15 0.00532 6.3
0.50 0.00743 6.5
ApoE341-299 0.15 0.00391 4.4
0.50 0.00502 4.9
1.00 0.00695 4.8
ApoE441-299 0.15 0.00384 3.7
0.50 0.00504 4.3
1.00 0.00773 4.3
ApoE372-299 0.15 0.00509 5.5
0.50 0.00537 5.7
1.00 0.00726 5.8
ApoE472-299 0.15 0.00413 6.4
0.50 0.00469 6.9
1.00 0.00726 7.2
ApoE31-191 0.15 0.00556 2.6
0.50 0.00654 2.9
ApoE41-191 0.15 0.00605 2.7
0.50 0.00713 3.0
ApoE31-231 0.15 0.00546 3.8
0.50 0.00660 4.2
ApoE41-231 0.15 0.00619 3.1
0.50 0.00772 3.6
ApoE31-271 0.15 0.00586 6.6
0.50 0.00740 6.3
ApoE41-271 0.15 0.00588 6.1
0.50 0.00728 6.1
*RMSD of best ﬁt to continuous c(s) distribution model with p ¼ 0.95.
ysw calculated by second moment integration (Schuck, 2003).
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apoE3 protein (6%). These observations support the greater
aggregation of apoE4 protein.
Size distribution of N-terminal truncated apoE3
and apoE4 proteins
Fig. 4, C and D, shows the best-ﬁt continuous c(s)
distribution of apoE341-299 and apoE441-299 proteins. In
size distribution from s ¼ 2.5–6.5 at p ¼ 0.55 (data not
shown), both apoE41-299 proteins showed two major species
of s ¼ 3.6–3.9 and 5.0–5.1. After calculating the integration
by SEDFIT, ﬁve species were identiﬁed for both apoE41-299
proteins (Table 2). At an initial protein concentration of
1.00 mg/ml, the major species of apoE341-299 with s ¼ 3.7
and 5.0 accounted for 77% of the total amount. In the
case of apoE441-299, the major species with s ¼ 3.6 and 5.1
constituted 72% of the total protein amount. Like those of
full-length apoE proteins, protein concentration inﬂuenced
the percentage of some species. In apoE341-299 protein, the
percentage of s ¼ 3.9 decreased by 16% and that of s ¼ 5.1
increased by 17% when the protein concentration was in-
creased from 0.15 to 1.00 mg/ml. ApoE441-299 showed a
7% decrease in s ¼ 3.7 and 8% increase in s ¼ 5.1 at higher
protein concentrations. However, both apoE41-299 proteins
showed less large species of s . 10 (decreased 1–4%).
Neither apoE341-299 nor apoE441-299 therefore showed a
tendency to aggregate.
Fig. 4, E and F, shows the best-ﬁt continuous c(s)
distribution of apoE372-299 and apoE472-299. ApoE472-299
(Fig. 4 F) showed a more complicated distribution pattern
than apoE372-299 (Fig. 4 F). The protein concentration had
a signiﬁcant inﬂuence on the distribution of species in
apoE472-299 solution. The major species in apoE372-299 was
s ¼ 5.9 at 1.00 mg/ml protein concentration, whereas those
in apoE472-299 were overlapping peaks separated into ﬁve
species: s ¼ 4.5, 6.1, 7.7, 9.3, and 11.0 (Fig. 4 F). After
calculating the integration by SEDFIT, both apoE72-299
proteins showed four species at 0.15 mg/ml protein
concentration (Table 2). However, when the protein
concentration was increased to 1.00 mg/ml, 10 species
were found in apoE472-299 protein, compared with ﬁve
species of apoE372-299 (Fig. 4, E and F). This feature showed
that aggregation of apoE472-299 protein was more sensitive to
concentration. The smallest apoE472-299 species with s ¼ 4.6
decreased by 4% at the higher protein concentration. At the
same time, species s ¼ 6.6 and 9.4 decreased by 24 and 8%,
respectively, species s ¼ 7.7 remained at 23%, and those
with s . 10 increased by 14%. Similar to the full-length
FIGURE 4 Continuous distribution analysis
of the apoE3 (A), apoE4 (B), apoE341-299 (C),
apoE441-299 (D), apoE372-299 (E), and
apoE472-299 proteins (F) at different concentra-
tions. Experiments were conducted at an initial
protein concentration of 0.15 (dotted line), 0.50
mg/ml (A and B, solid line; C–F, dashed line),
or 1.00 mg/ml (solid line) in PBS (pH 7.3) at
20C, rotor speed 40,000 rpm. Data were
collected at time intervals of 480 s. The
conﬁdence level of the regularization after
ﬁtting was p ¼ 0.68. (Insets) Grayscale of
residual bitmap.
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proteins, at higher protein concentrations, apoE472-299 had
more abundant larger species (s . 10, 21%), compared with
those of apoE372-299 (12%). ApoE472-299 therefore shows a
greater tendency to aggregate.
Size distribution of C-terminal truncated apoE3
and apoE4 proteins
Fig. 5, A and C, shows the best-ﬁt continuous c(s) dis-
tribution of the C-terminal truncated apoE proteins. At the
initial protein concentration of 0.15 mg/ml, both apoE31-191
and apoE41-191 existed as two major peaks with s ¼ 2.1 and
s ¼ 4.5 values (solid lines in Fig. 5, A and C). The two-
species distribution was still maintained in the case of the
apoE31-231 and apoE41-231 (dashed lines in Fig. 5, A and C),
whereas the s values were shifted to 2.4 and 5.5 and the ratio
of the two species also changed. From the results of c(M)
distribution, the mass of the two species were estimated to be
;22 kDa and 85 kDa for apoE1-191 and ;30–35 kDa and
110–140 kDa for apoE1-231 (Fig. 5, B and D). These two
species were assumed to be monomer and tetramer.
To further evaluate the association of monomer and
tetramer, the monomer-tetramer rapid self-association model
was used to calculate dissociation constants, Kd. The Kd of
apoE31-191 (556 6 233 nM) was 19 times larger than that of
apoE31-231 (296 2.8 nM) and 37 times in the case of apoE4
isoforms (592 6 323 nM of apoE41-191 and 16 6 1.3 nM of
apoE41-231). Both apoE31-231 and apoE41-231 showed greater
tendency toward tetramerization.
Different from the 1–191 and 1–231 fragments in size
distribution, apoE1-271 proteins showed overlapping peaks
(dotted lines in Fig. 5, A and C). After calculating the
integration area by SEDFIT, apoE31-271 could be resolved
into six species with s ¼ 3.6 (8%), 6.4 (64%), 8.9 (16%),
10.8 (8%), 13.2 (4%), and 17.4 (1%). The protein apoE41-271
showed a similar pattern with s ¼ 3.5 (4%), 5.6 (29%), 7.0
(29%), 8.4 (17%), 10.2 (13%), 13.2 (4%), and 17.3 (4%), but
it should be noted that there was a change in the relative
amounts of each species. Similar to the c(S) distribution,
continuous c(M) distribution (dotted lines in Fig. 5, B and D)
also showed overlapping peaks in the range of 50–400 kDa.
ApoE41-271 was made up of more and larger species (s. 10;
TABLE 2 Size distribution analysis of full-length and N-terminal truncated apoE3 and apoE4 proteins by serial integration
0.15 mg/ml 1.00 mg/ml*
Concentration Integral rangey (S) sw
z (S) Integral area Integral range (S) sw (S) Integral area
ApoE3 2.5–4.5 4.0 6 0.4 0.05 (13%)§ 3.4–4.9 4.3 6 0.3 0.12 (10%)
4.5–7.1 5.9 6 0.7 0.15 (38%) 4.9–7.2 6.1 6 0.6 0.34 (30%)
7.1–9.0 7.9 6 0.5 0.08 (21%) 7.2–9.3 8.2 6 0.6 0.30 (26%)
9.0–11.2 9.9 6 0.6 0.05 (13%) 9.3–11.0 10.0 6 0.5 0.15 (13%)
11.2–23.9 15.1 6 3.1 0.06 (15%) 11.0–23.1 14.6 6 3.1 0.24 (21%)
ApoE4 2.7–4.4 3.9 6 0.3 0.05 (13%) 3.2–4.7 4.1 6 0.3 0.12 (11%)
4.4–7.1 5.8 6 0.7 0.17 (45%) 4.7–6.7 5.8 6 0.5 0.25 (24%)
7.1–8.8 7.8 6 0.5 0.07 (18%) 6.7–8.5 7.6 6 0.5 0.24 (23%)
8.8–11.5 9.8 6 0.7 0.05 (13%) 8.5–10.4 9.4 6 0.5 0.17 (16%)
11.5–23.4 14.9 6 2.6 0.04 (11%) 10.4–24.4 14.6 6 3.5 0.28 (26%)
ApoE341-299 2.8–4.5 3.9 6 0.3 0.08 (38%) 2.8–4.1 3.7 6 0.3 0.28 (22%)
4.5–6.3 5.1 6 0.5 0.08 (38%) 4.1–6.5 5.0 6 0.6 0.70 (55%)
6.3–8.0 7.1 6 0.5 0.02 (9%) 6.5–8.1 7.2 6 0.5 0.12 (9%)
8.0–9.7 8.7 6 0.5 0.01 (5%) 8.1–9.9 8.9 6 0.5 0.06 (5%)
9.7–22.3 13.9 6 3.3 0.02 (10%) 9.9–22.8 14.2 6 3.3 0.12 (9%)
ApoE441-299 2.5–4.4 3.7 6 0.4 0.08 (38%) 2.5–4.2 3.6 6 0.3 0.42 (31%)
4.4–6.1 5.1 6 0.4 0.07 (33%) 4.2–6.2 5.1 6 0.5 0.55 (41%)
6.1–7.5 6.7 6 0.4 0.02 (10%) 6.2–7.7 6.8 6 0.4 0.16 (12%)
7.5–9.2 8.3 6 0.5 0.01 (5%) 7.7–9.6 8.6 6 0.5 0.08 (6%)
9.2–21.5 13.4 6 3.4 0.03 (14%) 9.6–22.9 13.7 6 3.4 0.14 (10%)
ApoE372-299 1.5–5.9 4.9 6 0.6 0.07 (47%) 1.7–8.2 5.9 6 1.1 0.72 (77%)
5.9–8.5 6.8 6 0.7 0.05 (33%) 8.2–10.3 9.1 6 0.6 0.10 (11%)
8.5–11.0 9.6 6 0.7 0.01 (7%) 10.3–22.8 14.0 6 3.1 0.11 (12%)
11.0–20.8 14.4 6 2.5 0.02 (13%)
ApoE472-299 3.0–5.2 4.6 6 0.5 0.02 (14%) 3.6–5.0 4.5 6 0.3 0.09 (10%)
5.2–8.1 6.6 6 0.8 0.08 (57%) 5.0–7.0 6.1 6 0.5 0.30 (33%)
8.1–11.7 9.4 6 1.0 0.03 (21%) 7.0–8.6 7.7 6 0.5 0.21 (23%)
11.7–20.1 13.9 6 1.9 0.01 (7%) 8.6–10.1 9.3 6 0.4 0.12 (13%)
10.1–23.6 13.5 6 3.1 0.19 (21%)
*Full-length apoE3 and apoE4 proteins were at 0.50 mg/ml.
ySedimentation coefﬁcient of continuous c(s) distribution model by SEDFIT (Schuck, 2000). The distributions were regularized by maximum entropy with
0.68 conﬁdence level.
zWeight-average sedimentation coefﬁcients calculated by SEDFIT.
§The area in different integral range was calculated by SEDFIT and values in parentheses were the area percentage.
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21%), compared to apoE31-271 (13%). However, they did not
show a signiﬁcant tendency to aggregate at higher protein
concentration (data not shown).
Dynamic light scattering of apoE proteins
To verify the size distribution of the apoE3, apoE4,
apoE372-299, and apoE472-299 proteins, DLS experiments
were performed at an initial protein concentration of
1.0mg/ml. Both apoE3 and E4 proteins showed a distribution
with two major particle groups, one with a size of 3.9 nm and
another in the range of 5.0–15.0 nm. However, apoE3 had
less 5.0–15.0 nm group particles (35%), compared with those
of apoE4 (46%). ApoE372-299 protein existed as one major
particle group in the range of 4–10 nm, whereas apoE472-299
showed two major groups with a particle size of 5.1 nm
(62%) and another in the range of 10.0–25.0 nm (36%).
Secondary structures of apoE proteins
Far-ultraviolet CD spectroscopy of apoE proteins is shown in
Fig. 6. Comparing the two isoforms, the spectra of full-
length apoE (circle lines in Fig. 6 A), 72–299 (square lines in
Fig. 6 A), and 1–271 (hexagon lines in Fig. 6 B) fragments
showed signiﬁcant difference. All spectral data were further
analyzed by the program CONTIN, SELCON3, and K2D.
Because these programs showed similar simulations, only
the results of CONTIN were shown in Table 3. ApoE3
protein indicated very high a-helical content (91%), whereas
that of apoE4 showed less (71%). The difference can also be
found when the apoE31-271 (78%) and apoE41-271 (69%)
proteins are compared. The N-terminal truncated fragments,
apoE341-299 and apoE441-299 proteins maintained ;54–55%
a-helix secondary structure and the percentage of random
coil had increased by 13% compared with apoE4 and 38%
compared with apoE3. ApoE372-299 protein showed rela-
tively low percentage of a-helical structure (38%), and high
percentage of random coil (53%). In contrast, apoE472-299
protein still maintained ;49% a-helix and showed less
random coil (47%).
In addition to the apoE1-271 proteins, the other C-terminal
truncated apoE fragments maintained;50–60% a-helix and
did not show an obvious difference between two isoforms.
ANS binding ability of apoE proteins
The binding of apoE proteins with the hydrophobic dye ANS
was studied by ﬂuorescence spectroscopy and the results are
shown in Fig. 7. ANS alone displayed very low ﬂuorescence
in aqueous buffer (Fig. 7, dotted lines) and its ﬂuorescence
was signiﬁcantly enhanced when bound to protein hydro-
phobic patches. Blue shift in the emission wavelength Ælæ
was observed after interaction with hydrophobic sites on
proteins (Table 4). In both the apoE3 and apoE4 isoforms,
the hydrophobic exposure of apoE41-299 proteins was always
higher than that of full-length apoE proteins (Fig. 7). In
addition, the hydrophobic exposure of the two isoforms did
not show a signiﬁcant difference in the case of the full-length
or 41–299 fragments. Although apoE72-299 protein had lower
hydrophobic exposure (compared with full-length and the
41–299 fragments), the apoE472-299 protein still showed
more hydrophobic exposure than apoE372-299 protein (20%
increase in ﬁt area; Table 4).
Different from the N-terminal truncated fragments, the
C-terminal truncation of the two isoforms did not show
signiﬁcant isoform difference. ApoE1-191 protein showed
very low hydrophobic exposure (only 35% of full-length
apoE) and less blue shift in Ælæ (triangle lines in Fig. 7 B;
FIGURE 5 Continuous distribution analysis
of C-terminal truncated apoE3 (A and B) and
apoE4 fragments (C and D). Experiments were
conducted in PBS (pH 7.3) at 20C, rotor speed
40,000 rpm. The left panels, continuous
sedimentation coefﬁcient distribution, c(s), and
the right panels, continuous molar mass dis-
tribution, c(M), of the truncated apoE3 and
apoE4 proteins (0.15 mg/ml). Solid lines,
apoE1-191; dashed lines, apoE1-231; and dotted
lines, apoE1-271. The conﬁdence level of the
regularization for 1–191 and 1–231 fragments
was 0.95 and for 1–271 was 0.68. (Insets)
Grayscale of residual bitmap.
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Table 4). Compared with apoE1-191 protein, the hydrophobic
exposure of apoE1-231 protein showed a large increase
(diamond lines in Fig. 7 B). ApoE1-271 showed the most
hydrophobic exposure (hexagon lines in Fig. 7 B), and ﬁt
area had increased by 60%, compared with full-length apoE
protein.
DISCUSSION
Structural variations governing the differences in higher-
order structures and protein aggregation for apoE3 and
apoE4, with only one Cys-Arg substitution at position 112,
are most useful for linking apoE isoform structures with the
molecular pathogenesis of atherosclerosis and AD. In this
study, we purposely truncated the ﬁrst and second helices in
the N-terminal domain of apoE, while maintaining the lipid-
interacting C-terminal domain with the aim of examining the
roles of helices 1 and 2 in helix stability and domain-domain
interactions. In addition, apoE with extensive C-terminal
helices truncation was also studied to understand structure
variation that may exist in the C-terminus.
This study elucidated structural variance between apoE3
and apoE4 isoforms at secondary, tertiary, and quaternary
structure levels. ApoE4 showed a higher percentage of
randomly coiled structure, compared with apoE3. This may
result in a greater tendency to aggregate for apoE4 than
apoE3. In the continuous c(s) distribution analyses, full-
length apoE3 and apoE4 showed very similar patterns when
the initial protein concentration was increased from 0.15 to
0.50 mg/ml. Concentration-dependent variation was ob-
served and large species with s . 10 was more signiﬁcantly
increased for apoE4 protein (by 15%), compared with that of
apoE3 protein (6%). The distribution patterns were different
from those of a previous report (Perugini et al., 2000).
However, a higher percent self-association of apoE4 isoform
was found and this agrees with the previous report.
When helix 1 only or helices 1 and 2 of the N-terminal
domain were truncated, the structural variance of apoE3 and
apoE4 became more signiﬁcant. The size distribution of
apoE341-299 and apoE441-299 showed minor variance in the
percentage of major species, whereas apoE372-299 and
apoE472-299 showed signiﬁcant differences in the secondary,
tertiary, and quaternary structures. ApoE472-299 protein
maintained more a-helical structure. The accessibility of
hydrophobic residues was also higher than for apoE372-299.
These features showed that in addition to the salt bridge
between Arg-61 and Glu-255, additional interactions may
exist to maintain the structure of apoE472-299 protein. In
addition, apoE472-299 showed a large amount of aggregation,
especially at a high protein concentration. From the DLS
experiments, the particle size of apoE472-299 protein was also
larger than that of apoE372-299. It can be explained by the
deletion of Arg-61. . .Glu-255 salt bridge (Dong et al., 1994;
Dong and Weisgraber, 1996). Deletion of the N-terminal
helices 1 and 2 of apoE3 protein resulted in the loss of most
of the secondary structure and yet its major species at s¼ 5.9
was maintained. These observations suggested that the ﬁrst
FIGURE 6 CD spectra of full-length and truncated apoE proteins. The
spectra were measured in PBS (pH 7.3). In panel A, closed circles, apoE3;
open circles, apoE4; closed triangles, apoE341-299; open triangles,
apoE441-299; closed squares, apoE372-299; open squares, apoE472-299. In
panel B, closed triangles, apoE31-191; open triangles, apoE41-191; closed
diamonds, apoE31-231; open diamonds, apoE41-231; closed hexagons,
apoE31-271; open hexagons, apoE41-271.
TABLE 3 Secondary structures of full-length and truncated
apoE3 and apoE4 proteins analyzed by CD spectroscopy
a-Helix
(%)
b-Sheet
(%)
Random
coil (%)
Normalized
RMSD
ApoE3 91.2* 6.9 2.0 0.076
ApoE4 70.9 3.5 25.6 0.052
ApoE341-299 55.3 5.0 39.6 0.048
ApoE441-299 56.5 5.0 38.4 0.057
ApoE372-299 37.6 8.8 53.4 0.048
ApoE472-299 48.5 5.0 46.5 0.075
ApoE31-191 53.0 4.5 42.6 0.066
ApoE41-191 60.1 7.4 32.6 0.091
ApoE31-231 58.1 4.5 37.4 0.043
ApoE41-231 56.8 5.0 38.3 0.079
ApoE31-271 77.7 2.0 20.3 0.030
ApoE41-271 68.8 2.1 29.0 0.048
*Percentage calculated by CONTIN program (Sreerama et al., 1999).
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two helices of N-terminal domain may play an important role
in the structure stability of apoE3.
Farkas et al. (2004) have showed that the intracellular
recycling of apoE and its N-terminal domain in vivo occur
via multiple redundant pathways. In addition, Li et al. (2003)
have suggested that the receptor 2 binding motif of apoE
is localized at the N-terminus. These studies indicate that
structural variance in the N-terminal truncated apoE3 and
apoE4 may lead to different degradation or recycling
pathways. The higher stability of truncated apoE4 proteins
may extend the half-life inside or outside the cells, and may
further lead to the formation of extracellular aggregated
plaques or NFT, the hallmark of AD.
Another point of view was raised by Saito et al. (2001,
2003) and Morrow et al. (2002) and they suggested that the
N-terminal domain of apoE4 (residues 1–191) form a molten
globule and assume an open or a closed form in the absence
or presence of lipid binding, respectively. Change in pH will
induce a similar structural change. This phenomenon may be
involved in the VLDL-binding efﬁciency of apoE4 proteins.
Our results showed that apoE472-299 had a higher hydropho-
bic exposure, suggesting higher lipid-binding afﬁnity, com-
pared to apoE372-299.
The oligomerization of apoE protein is also closely related
to the length of its C-terminal domain. From our results, the
apoE1-191 protein existed mainly as monomer with some
tetramer. When the helix 1 of C-terminal domain remained
(192–231), the tetramer content was increased and monomer
content was decreased. The apoE1-271 protein showed signiﬁ-
cant polymerization and the major species were assumed to
be tetramers to hexamers (100–200 kDa, Fig. 5,B andD). Fan
et al. (2004) indicated that the G* helix (268–289) is the key
motif for the apoE aggregation. Our results suggest that the
helices 1 and 2 of C-terminal domain (192–270) also induce
polymerization of the apoE and that the Kd of apoE1-231 is
signiﬁcantly decreased and the polymerization of apoE1-271 is
signiﬁcant, as compared to apoE1-191 or apoE1-231. In contrast
to the N-terminal truncation, C-terminal truncation of apoE3
and apoE4 proteins did not induce any signiﬁcant variation.
On the other hand, apoE C-terminal domain seemed to play
an important role in the protein self-association of both apoE3
and apoE4.
Choy et al. (2004) suggested that there is an intermolecular
coiled-coil formation in the apoE C-terminal domain. By
sedimentation equilibrium studies, the dimer-tetramer-oc-
tamer model is suggested in the lipid-free environments,
whereas the monomer-dimer-tetramer model is well main-
tained in the presence of 50% triﬂuoroethanol. Our sedimen-
tation velocity studies showed that the only species present for
the apoE C-terminal domain is a tetramer (s ¼ 3.0) in PBS
and the major species is a dimer (s ¼ 1.5) in the presence
of dihexanoylphosphatidylcholine (T. H. Lin, unpublished
data).
The function of apoE to lower plasma cholesterol in vivo
was checked by injection of proteins into apoE() mice
(C. Y. Chou, G. G. Chang, and M. S. Shiao, unpublished
FIGURE 7 Binding of full-length and truncated apoE isoform proteins
with ANS as a ﬂuorescence probe. A ﬁxed concentration of ANS (250 mM)
and proteins (3 mM) was used. Excitation wavelength was set at 395 nm.
The minimum ﬂuorescence of ANS in PBS (pH 7.3) at 25C was shown
by dotted lines. In panel A, closed circles, apoE3; open circles, apoE4;
closed squares, apoE341-299; open squares, apoE441-299; closed triangles,
apoE372-299; open triangles, apoE472-299. In panel B, closed triangles,
apoE31-191; open triangles, apoE41-191; closed diamonds, apoE31-231; open
diamonds, apoE41-231; closed hexagons, apoE31-271; open hexagons,
apoE41-271.
TABLE 4 The ANS ﬂuorescence emission spectrum analysis
Sample*y Fit area (nm 3 AU) (3 103) Ælæ (nm)
Buffer only 1.8 512
ApoE3 27.6 485
ApoE4 27.0 485
ApoE341-299 32.4 485
ApoE441-299 31.4 485
ApoE372-299 20.8 486
ApoE472-299 25.2 486
ApoE31-191 9.3 490
ApoE41-191 10.0 489
ApoE31-231 21.5 486
ApoE41-231 23.8 486
ApoE31-271 45.3 485
ApoE41-271 43.4 485
*Fixed concentration of ANS (250 mM) was used.
yDetermination was conducted in PBS at pH 7.3 at 25C.
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data). The functional assay showed that full-length and
truncated apoE proteins were active in vivo. Animal studies
were conducted using apoE isoform proteins in pairs. Our
preliminary results indicate that full-length apoE3 and
apoE4, apoE341-299, apoE441-299, and apoE472-299 lowered
the plasma cholesterol to a similar extent. However, the
efﬁcacy of apoE372-299 was signiﬁcantly lower than that of
full-length or apoE472-299 (30% less). This correlates well
with helix 2 in the N-terminus being involved in the LDL
receptor binding, especially for apoE3. One possibility is that
stabilization by helix 2 to the LDL receptor binding of apoE3
proteins is more important than that of two-domain interac-
tions. The more stabilized apoE4 isoform, which may assist
in the domain-domain interaction, is less affected by helix 2
truncation. Other stabilization interactions may exist beyond
the interaction of Arg-61 with Glu-255 and these may sta-
bilize an extended helical structure in the carboxyl terminus
to accommodate a larger, less-curved VLDL surface (Dong
and Weisgraber, 1996).
Huang et al. (2001) have shown that C-terminal truncated
fragments of apoE4 (272–299 amino acids removed) is
generated inside cultured neurons and in brains of AD
patients and interacted with p-tau and p-NF-H, resulting in
large, ﬁlamentous intracellular inclusions resembling NFT in
AD brains. When residues 245–271 in the C-terminus is
deleted, the ability of apoE4 to form intracellular inclusions is
completely lost. They have also found that N-terminal
truncated apoE4 (1–85 residues removed) induces more
NFT in culture neurons. The higher aggregation tendency
of N-terminal truncated apoE4 and the importance of the
C-terminus (232–271) in the self-association observed in our
study may be due to the same reason. The ﬁndings for
structural variation in N-terminal truncated apoE3 and apoE4
provide useful information to explain the higher levels of
aggregation of the E4 isoform and this supports the involve-
ment of E4 in AD. Our studies thus provide a direction for the
rational design of drugs that may inhibit the aggregation of
apoE4 and targeting this may delay the formation of NFT or
extracellular amyloid plaques.
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